Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Victor Jiménez-Yuste"'
Autor:
Jan Astermark, Jan Blatný, Christoph Königs, Cédric Hermans, Victor Jiménez-Yuste, Daniel P. Hart
Publikováno v:
Therapeutic Advances in Hematology, Vol 14 (2023)
Recent advances in therapeutics are now providing a wide range of options for adults and children living with hemophilia. Although therapeutic choices are also increasing for the youngest individuals with severe disease, challenges remain about early
Externí odkaz:
https://doaj.org/article/69ffcda2103145819b48cedc4e3af5bb
Autor:
Daniel P. Hart, Davide Matino, Jan Astermark, Gerard Dolan, Roseline d’Oiron, Cédric Hermans, Victor Jiménez-Yuste, Adriana Linares, Tadashi Matsushita, Simon McRae, Margareth C. Ozelo, Sean Platton, Darrel Stafford, Robert F. Sidonio, Andreas Tiede
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Haemophilia B is a rare X-linked genetic deficiency of coagulation factor IX (FIX) that, if untreated, can cause recurrent and disabling bleeding, potentially leading to severe arthropathy and/or life-threatening haemorrhage. Recent decades have brou
Externí odkaz:
https://doaj.org/article/6d7e378037764148859c121950d01992
Autor:
Carmen Escuriola Ettingshausen, Vladimír Vdovin, Nadezhda Zozulya, Pavel Svirin, Tatiana Andreeva, Majda Benedik-Dolničar, Victor Jiménez-Yuste, Lidija Kitanovski, Silva Zupancic-Šalek, Anna Pavlova, Angelika Bátorová, Cesar Montaño Mejía, Gulnara Abdilova, Sigurd Knaub, Martina Jansen, Shannely Lowndes, Larisa Belyanskaya, Olaf Walter, Johannes Oldenburg
Publikováno v:
TH Open, Vol 06, Iss 02, Pp e124-e134 (2022)
Background Immune tolerance induction (ITI) with repeated factor VIII (FVIII) administration is the only strategy proven to eradicate inhibitors. The observational ITI study is evaluating ITI with a range of FVIII products. Methods This subgroup anal
Externí odkaz:
https://doaj.org/article/a52b126df9af4fd18ab2a85705afdb71
Autor:
Pratima Chowdary, Manuel Carcao, Pål A. Holme, Victor Jiménez‐Yuste, Steven R. Lentz, Judi Møss, Lone H. Poulsen, Chunduo Shen, Alberto Tosetto, Allison Wheeler, Elena Santagostino
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 3, Pp 542-554 (2019)
Abstract Background N8‐GP is an extended half‐life recombinant factor VIII developed for prophylaxis and treatment of bleeds in patients with hemophilia A. Objective To assess pharmacokinetic (PK) characteristics of N8‐GP in previously treated
Externí odkaz:
https://doaj.org/article/9e72b2ac203c43c88c631ec0301b622f
Autor:
Andreas Tiede, Peter Collins, Paul Knoebl, Jerome Teitel, Craig Kessler, Midori Shima, Giovanni Di Minno, Roseline d’Oiron, Peter Salaj, Victor Jiménez-Yuste, Angela Huth-Kühne, Paul Giangrande
Publikováno v:
Haematologica, Vol 105, Iss 7 (2020)
Acquired hemophilia A (AHA), a rare bleeding disorder caused by neutralizing autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without a previous history of bleeding. Patients typically present with an isolated prol
Externí odkaz:
https://doaj.org/article/1c8ffa7fc0454ea784fffd40ad887d2c
Autor:
Andreas Tiede, Faraizah Abdul Karim, Victor Jiménez-Yuste, Robert Klamroth, Sandra Lejniece, Takashi Suzuki, Andreas Groth, Elena Santagostino
Publikováno v:
Haematologica, Vol 106, Iss 7 (2020)
During factor VIII prophylaxis for severe hemophilia A, bleeding risk increases with time when factor VIII activity is below 1%. Maintaining trough activity above 1% does not protect all patients from bleeding. The relationship between factor VIII ac
Externí odkaz:
https://doaj.org/article/be122ee822dd43b8be3939c21697923a
Autor:
Carmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, Karem Humala, Ana López de la Guia, Raquel De Paz, Mercedes Gasior, Pilar Gómez Prieto, Marta Fabra Urdiola, Miguel Canales Albendea, Nora Butta, Victor Jiménez Yuste
Publikováno v:
Disease Markers. 2023:1-9
Background. Sinusoidal obstructive syndrome (SOS) is a potentially fatal complication secondary to hematopoietic stem cell transplant (HSCT) conditioning. Endothelial damage plasma biomarkers such as plasminogen activator inhibitor-1 (PAI-1), hyaluro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a014e01c3b459b059fff6f8b62ac8113
https://doi.org/10.1155/2023/7589017
https://doi.org/10.1155/2023/7589017
Autor:
Maria Isabel Bravo, Alba Pérez, Aida Raventós, Salvador Grancha, Juan Ignacio Jorquera, Nora Viviana Butta, Maria Teresa Álvarez‐Román, Montserrat Costa, Todd Willis, Victor Jiménez‐Yuste
Publikováno v:
Haemophilia. 28:737-744
Presence of von Willebrand factor (VWF) in FVIII concentrates offers protection against neutralizing inhibitors in haemophilia A (HA). Whether this protection is more evident in plasma-derived (pd) FVIII/VWF or recombinant (r) FVIII concentrates rema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a49442acfb8e9f86221b54e6924900
https://doi.org/10.1111/hae.14589
https://doi.org/10.1111/hae.14589
Autor:
Ihosvany Fernandez-Bello, Paula Acuña, Carolina Cubillos-Zapata, Begoña Sánchez, Elena Monzón Manzano, Raul Justo Sanz, Ana Jaureguizar, Francisco García Rio, Nora Butta, Alberto Alonso-Fernández, María Teresa Álvarez Román, Raquel Casitas, Victor Jiménez Yuste
Publikováno v:
Archivos de Bronconeumología. 58:117-124
Introduction Growing evidence shows a hypercoagulable state in obstructive sleep apnea (OSA) that could be a risk factor for thromboembolic disease. Objectives We aimed to elucidate mechanisms involved in the procoagulant profile observed in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25c539f96316eee57d916ad7a3ecc2a3
https://doi.org/10.1016/j.arbres.2020.11.017
https://doi.org/10.1016/j.arbres.2020.11.017
Autor:
Raquel Olivas-Mazón, Alba Fernández-Arroyo, Antonio Marcos, Ana Belén Romero, Victor Jiménez Yuste, Aida Constanzo, Antonio Balas, David Bueno, Cristina Ferreras, Mercedes Gasior, Jose L. Vicario, Antonio Pérez-Martínez, Berta González, Raquel de Paz, Yasmina Mozo, Isabel Mirones, Luisa Sisinni, Adela Escudero, Juan Torres Canizales
Publikováno v:
Transfusion. 61:1505-1517
Background Naive T-cell-depleted grafts have been employed as an ex vivo T-cell depletion (TCD) platform to prevent graft-versus-host disease (GvHD) and improve immune reconstitution by providing rapid donor memory T-cell reconstitution after allogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c162cab84eb218fae5398693300b19
https://doi.org/10.1111/trf.16354
https://doi.org/10.1111/trf.16354